Patents by Inventor Alan Hastings Drummond

Alan Hastings Drummond has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090291978
    Abstract: Compounds of formula (I) are inhibitors of histone deacetylase activity, and are useful in the treatment of, for example, cancers, wherein R1 is a carboxylic acid group (—COOH), or an ester group which is hydrolysable by one or more intracellular carboxyesterase enzymes to a carboxylic acid group; R2 is the side chain of a natural or non-natural alpha amino acid; Y is a bond, C(?O)—, —S(?O)2—, —C(—O)O—, —C(O)NR3—, —C(?S)—NR3, —C(?NH)NR3 or —S(?O)2NR3— wherein R3 is hydrogen or optionally substituted C1-C6 alkyl; L is a divalent radical of formula -(Alk1)m(O)n(Alk2)p— wherein m, n and p are independently 0 or 1, Q is (i) an optionally substituted divalent mono- or bicyclic carbocyclic or heterocyclic radical having 5-13 ring members, or (ii), in the case where both m and p are 0, a divalent radical of formula —X2-Q1- or -Q1-X2— wherein X2 is —O—, S— or NRA— wherein RA is hydrogen or optionally substituted C1-C3 alkyl, and Q1 is an optionally substituted divalent mono- or bicyclic carbocyclic or hetero-cyclic r
    Type: Application
    Filed: May 4, 2006
    Publication date: November 26, 2009
    Applicant: CHROMA THERAPEUTICS LTD.
    Inventors: Alan Hornsby Davidson, Sanjay Ratilal Patel, Francesca Ann Mazzei, Stephen John Davies, Alan Hastings Drummond, David Festus Moffat, Kenneth William John Baker, Alistair David Graham Donald
  • Publication number: 20090215800
    Abstract: Covalent conjugation of an alpha amino acid ester to a modulator of the activity of a target intracellular enzyme or receptor, wherein the ester group of the conjugate is hydrolysable by one or more intracellular carboxylesterase enzymes to the corresponding acid, leads to accumulation of the carboxylic acid hydrolysis product in the cell and enables improved or more prolonged enzyme or receptor modulation relative to the unconjugated modulator.
    Type: Application
    Filed: May 4, 2006
    Publication date: August 27, 2009
    Applicant: CHROMA THERAPEUTICS LTD
    Inventors: Alan Hornsby Davidson, Alan Hastings Drummond, Lindsey Ann Needham
  • Publication number: 20030149084
    Abstract: This invention provides a method of inhibiting proliferation of tumor cells in a subject by administering to the subject an effective amount of ester and thioester compounds containing an N-formyl hydroxylamine group.
    Type: Application
    Filed: December 10, 2002
    Publication date: August 7, 2003
    Inventors: Andrew Paul Ayscough, Lisa Marie Pratt, Alan Hastings Drummond
  • Patent number: 6495597
    Abstract: Compounds of formula (I) wherein R4 is an ester or thioester group and R, R1, R2 and R3 are as defined in the specification, inhibit proliferation of tumor cells.
    Type: Grant
    Filed: October 5, 2000
    Date of Patent: December 17, 2002
    Assignee: British Biotech Pharmaceuticals Ltd.
    Inventors: Andrew Paul Ayscough, Lisa Marie Pratt, Alan Hastings Drummond
  • Patent number: 6169075
    Abstract: Compounds of formula 1 wherein R4 is an ester or thioester group, and R, R1, R2 and R3 are as defined in the specification are inhibitors of rapidly dividing tumour cells.
    Type: Grant
    Filed: September 8, 1997
    Date of Patent: January 2, 2001
    Assignee: British Biotech Pharmaceuticals Limited
    Inventors: Lindsey Ann Pearson, Andrew Paul Ayscough, Philip Huxley, Alan Hastings Drummond